Dr Brad has been nominated for the Complementary Medicines Australia (CMA) Board

I have been nominated for the Complementary Medicines Australia (CMA) Board.

Worldwide, Australian complementary medicine products are highly regarded as safe, effective, and of the highest quality.

My vision for the direction for the Australian Complementary Medicines Industry is to:

  • Increase public health and wellbeing, quality of life, physical, mental, and emotional wellbeing, and reduce the burden of chronic disease of Australians, now and for future generations, through education and information on the use of complementary medicines.
  • Increase the research and education of complementary medicines and health foods through supporting programs.
  • Support and enhance a robust complementary healthcare products industry through advocacy and promotion.
  • Support the ethical and responsible promotion and use of complementary medicines through education.
  • Strengthen the position of CMA internationally and enhance its reputation as a leader of complementary medicine.
  • Increase, foster, and strengthen the position of the CMA members through advocacy and promotion.
  • Strengthen the position of complementary medicine in the media, by promoting CMA members being the first choice of expertise in their areas.
  • Enhance the support of manufacturers, importers, exporters, raw material suppliers, wholesalers, distributors, consultants, and retailers.
  • Enhance the positive interaction with Government and non-Government organisations of the benefits of complementary medicines on improving health and wellbeing and reducing the burden and impact of chronic disease on quality of life as well as the economy.
  • Enhance the relationships with industry partners, professional bodies, associations, and consumers through advocacy.
  • Provide stability, strength, and sustainability of the industry through advocacy, support, and promotion.

If you are a CMA member, please vote. I will do my best to represent you.

%d bloggers like this: